These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 3446162

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Use of methylprednisolone as prophylaxis for immediate adverse infusion reactions in hypogammaglobulinaemic patients receiving intravenous immunoglobulin: a controlled trial.
    Roberton DM, Hosking CS.
    Aust Paediatr J; 1988 Jun; 24(3):174-7. PubMed ID: 3048235
    [Abstract] [Full Text] [Related]

  • 5. Self-infusion of intravenous immunoglobulin by immunodeficient patients at home.
    Ochs HD, Lee ML, Fischer SH, Delson ES, Chang BS, Wedgwood RJ.
    J Infect Dis; 1987 Oct; 156(4):652-4. PubMed ID: 3624908
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs.
    Gardulf A, Andersen V, Björkander J, Ericson D, Frøland SS, Gustafson R, Hammarström L, Jacobsen MB, Jonsson E, Möller G.
    Lancet; 1995 Feb 11; 345(8946):365-9. PubMed ID: 7845120
    [Abstract] [Full Text] [Related]

  • 9. Adverse reactions in a large cohort of patients with inborn errors of immunity receiving intravenous immunoglobulin.
    Esmaeilzadeh H, Askarisarvestani A, Hosseini N, Samimi S, Shafiei A, Mahdaviani SA, Eslami N, Chavoshzadeh Z, Fallahi M, Khakbazanfard N, Shabestari MS, Aleyasin S, Nabavizadeh SH, Cheraghi T, Kalantari A, Ahmadiafshar A, Safari M, Eslamian MH, Molatefi R, Shirkani A, Heidarzadeh Arani M, Tavakol M, Bemanian MH, Arshi S, Nabavi M, Shokri S, Shahhosseini B, Mortazavi N, Nakhaei P, Nazari F, Fallahpour M, Ahanchian H, Moazzen N, Khoshkhui M, Motlagh AV, Aghamohammadi A, Abolhassani H, Yazdani R, Rezaei N.
    Clin Immunol; 2021 Sep 11; 230():108826. PubMed ID: 34418548
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of a new intravenous immunoglobulin preparation in primary immunodeficient patients.
    Ochs HD, Lee ML, Fischer SH, Kingdon HS, Wedgwood RJ.
    Clin Ther; 1987 Sep 11; 9(5):512-22. PubMed ID: 3117369
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Non-A non-B hepatitis and the safety of intravenous immune globulin, pH 4.2: a retrospective survey. Preliminary communication.
    Rousell RH, Good RA, Pirofsky B, Schiff RI.
    Vox Sang; 1988 Sep 11; 54(1):6-13. PubMed ID: 3126601
    [Abstract] [Full Text] [Related]

  • 20. Intravenous immunoglobulin therapy for antibody deficiency.
    Nolte MT, Pirofsky B, Gerritz GA, Golding B.
    Clin Exp Immunol; 1979 May 11; 36(2):237-43. PubMed ID: 477026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.